Menu
Montecito
PacPremier
Loading...
You are here:  Home  >  'serimmune'
Latest

Goleta-based biotech Serimmune appoints new CEO

By   /  Tuesday, August 6th, 2019  /  Biotech, Central Coast Health Watch, Latest news, South Coast, Technology  /  Comments Off on Goleta-based biotech Serimmune appoints new CEO

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Serimmune issues $1.4 million in promissory notes

By   /  Tuesday, June 11th, 2019  /  Biotech, Central Coast Health Watch, Latest news, South Coast, Startups, Technology  /  Comments Off on Serimmune issues $1.4 million in promissory notes

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Winners of the 2018 Central Coast Innovation Awards announced

By   /  Tuesday, February 27th, 2018  /  Latest news  /  Comments Off on Winners of the 2018 Central Coast Innovation Awards announced

The Pacific Coast Business Times is pleased to announce our 2018 winners of the Central Coast Innovation Awards. This annual special section, now in its third year, published with the Feb. 23 print edition. A two-part event on Thursday, March 15 begins with Startup Village and concludes with an evening awards reception for the honorees Read More →

Read More →
Latest

SerImmune gets $8 million in financing from Illumina Ventures

By   /  Thursday, June 22nd, 2017  /  Central Coast Health Watch, Latest news, Technology, Tri-County Public Companies  /  Comments Off on SerImmune gets $8 million in financing from Illumina Ventures

Santa Barbara immunotherapy and diagnostic company SerImmune received $8 million in financing from San Francisco-based Illumina Ventures to expand its immune mapping platform and database. Illumina invests primarily in early-stage companies researching genomics, life science and health care. A subsidiary of pharmaceutical giant Merck also participated in the financing round, alongside other undisclosed investors. Mapping Read More →

Read More →
Latest

Diagnostic companies aim to disrupt medical industry

By   /  Friday, December 9th, 2016  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Diagnostic companies aim to disrupt medical industry

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Getting a grip on diabetes: Aptitude device gets fast track status for clinical trials

By   /  Friday, October 24th, 2014  /  Central Coast Health Watch, Latest news, Subscriber content, Technology, Top Stories  /  Comments Off on Getting a grip on diabetes: Aptitude device gets fast track status for clinical trials

Aptitude creates a special type of molecule called an aptamer, which it is using to develop a first-of-its-kind hand-held device that measures insulin concentrations in real-time and can diagnose pre-diabetes. The government’s interest in furthering such research is unsurprising as diabetes affects more than 9 percent of Americans.

Read More →